HealthEquity Inc HQY: Investors are paying attention to this stock

The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Measures how much net income or profit is generated as a percentage of revenue.

The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool.

HealthEquity price target upped to $68 from $55 at SunTrust

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401, Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.

According to analysts’ consensus price target of $80.62, HealthEquity has a forecasted upside of 36.6% from its current price of $59.00. Raw Stochastic average of HealthEquity Inc. in the period of last 50 days is set at 1.03%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.03%. In the last 20 days, the company’s Stochastic %K was 30.05% and its Stochastic %D was recorded 55.79%.

HealthEquity Sets Date to Announce Third Quarter Results

Provide specific products and services to you, such as portfolio management or data aggregation. Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. HQY typically sells its solutions to employers, who then offer them to their employees. The company also manages other common employee benefits that complement its HSA offerings.

There really aren’t any good comps to value HQY off of, now that it purchased WageWorks. Historically, the company has commanded a healthy EV/EBITDA multiple, often over 40x. When it reported its Q3 results in December, HQY not only increased its FY23 forecast for the currencies, conversions, and taxes 4th straight quarter, in an unusual move it also provided FY24 guidance. When looking at risks, a drop in interest rates would be negative. That said, this is a company that had become accustomed to a low rate environment that is suddenly seeing a nice benefit.

Research Reports for HQY

Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. We’d like to share more about how we work and what drives our day-to-day business. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

• HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions.
• That said, according to HQY, the average HSA balance is only $3,000 per participants, so there is a lot of potential upside for balance to grow.
• The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades.

Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time. Verify your identity, personalize the content you receive, or create and administer your account. Paris covers the Services sector, focusing on stocks such as Grand Canyon Education, H&R Block, and Universal Technical Institute. I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.

About MarketBeat

This provider of services for managing health care accounts is expected to post quarterly earnings of $0.34 per share in its upcoming report, which represents a year-over-year change of +70%. Revenues are expected to be $229.43 million, up 12.9% from the year-ago quarter. HealthEquity saw a increase in short interest during the month of February.

Let’s start up with the current stock price of HealthEquity Inc. , which is $52.44 to be very precise. The Stock rose vividly during the last session to $59.74 after opening rate of $58.60 while the lowest price it went was recorded $52.27 before closing at $61.68. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer.

Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 10 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for HealthEquity in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock.

For HealthEquity, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock’s price usually doesn’t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on HQY going forward to see if this recent jump can turn into more strength down the road.

Quotes & News

Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could “deliver huge returns.” Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years. The mean of analysts’ price targets for HealthEquity points to a 29.9% upside in the stock.

While this highly sought-after metric has not proven reasonably effective, strong agreement among anal… The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -14.93%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -21.66%, alongside a downfall of -2.29% for the period of the last 12 months. The shares increased approximately by -20.55% in the 7-day charts and went down by -13.08% in the period of the last 30 days. Common stock shares were lifted by -18.89% during last recorded quarter. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Meanwhile, outside of rates, HSA is a nice, steady growing business. At this point, the biggest risk for HQY right now might be high expectations. Based on the FY24 EBITDA consensus of $325.4 million, HQY trades at an EV/EBITDA https://day-trading.info/ multiple of about 19.5x. Based on the FY25 EBITDA estimate of $404.5 million, it trades at about 15.8x. Solid job creation has been a driver for HSA usage growth, and this tailwind could turn into more of a headwind in 2023.

The consensus among Wall Street equities research analysts is that investors should “buy” HQY shares. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. For Natera , the consensus EPS estimate for the upcoming report has changed +5.8% over the past month to -$1.17.

69.0% of employees surveyed would recommend working at HealthEquity to a friend. HealthEquity has a short interest ratio (“days to cover”) of 3.9, which is generally considered an acceptable ratio of short interest to trading volume. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. HealthEquity witnesses solid growth in HSAs, besides recording robust performances in majority of its segments, in the second quarter of fiscal 2023.

In a report released on March 7, BTIG also maintained a Buy rating on the stock with a $85.00 price target. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance.